相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Covalent peptides and proteins for therapeutics
Viktoriya Y. Berdan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Aptamer-Directed Protein-Specific Multiple Modifications of Membrane Glycoproteins on Living Cells
Xigao Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics
Qingke Li et al.
CELL (2020)
Recent Advances in Aptamer Discovery and Applications
Yang Zhang et al.
MOLECULES (2019)
Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX
Koji Wakui et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
Luca Gambini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
Qinheng Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Tatsuo Adachi et al.
MOLECULES (2019)
The growing applications of SuFEx click chemistry
A. S. Barrow et al.
CHEMICAL SOCIETY REVIEWS (2019)
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation
Tinghu Zhang et al.
CELL CHEMICAL BIOLOGY (2019)
The reactivity-driven biochemical mechanism of covalent KRAS(G12C) inhibitors
Rasmus Hansen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
The reactivity-driven biochemical mechanism of covalent KRAS(G12C) inhibitors
Rasmus Hansen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Rapid Complexation of Aptamers by Their Specific Antidotes
Heidi Stoll et al.
MOLECULES (2017)
A study of the reactivity of S(VI)-F containing warheads with nucleophilic amino-acid side chains under physiological conditions
H. Mukherjee et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Covalent inhibitors: an opportunity for rational target selectivity
Roman Lagoutte et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins
Yanou Yang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Targeted Covalent Inhibitors for Drug Design
Thomas A. Baillie
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Drug-Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization
Jinping Gan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
Renato A. Bauer
DRUG DISCOVERY TODAY (2015)
Aptamer Selection Technology and Recent Advances
Michael Blind et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
Jiajia Dong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Kinetic characterization of inhibition of human thrombin with DNA aptamers by turbidimetric assay
Elena G. Zavyalova et al.
ANALYTICAL BIOCHEMISTRY (2012)
Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents
K. M. Bompiani et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity
Irene Russo Krauss et al.
NUCLEIC ACIDS RESEARCH (2012)
Immune pathomechanism of drug hypersensitivity reactions
Werner J. Pichler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Strategies for discovering and derisking covalent, irreversible enzyme inhibitors
Douglas S. Johnson et al.
FUTURE MEDICINAL CHEMISTRY (2010)
Beyond Picomolar Affinities: Quantitative Aspects of Noncovalent and Covalent Binding of Drugs to Proteins
Adam J. T. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Antidote-mediated control of an anticoagulant aptamer in vivo
CP Rusconi et al.
NATURE BIOTECHNOLOGY (2004)
Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration - Phase II study results
G Fish et al.
OPHTHALMOLOGY (2003)
RNA aptamers as reversible antagonists of coagulation factor IXa
CP Rusconi et al.
NATURE (2002)
分享论文
